CoreAge Rx vs Nex Gen Health Rx
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Nex Gen Health Rx head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
Nex Gen Health Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 68 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make Nex Gen Health Rx a bad call — it's best for readers who can obtain the selected supply, complete charge and pharmacy handling instructions before paying for a longer plan. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | Nex Gen Health Rx |
|---|---|---|
| Brief Score | 94/100 (A) | 68/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | Confirm offer, supply and total Homepage from $99/month; injection page starts at $190. The selected offer and full payment are unconfirmed. Injection pages list 30-, 90-, 180- and 360-day supply options. Confirm formulation, supplied quantity and renewal terms. Full price detailsCompounded semaglutide offered; complete current selected-plan quote unknown; homepage advertises from $99/month while injection page starts at $190 with different supply options; earlier listing: From $190/mo (compounded) |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | Confirm offer, supply and total Homepage from $149/month; injection page starts at $239. The selected offer and full payment are unconfirmed. Injection pages list 30-, 90-, 180- and 360-day supply options. Confirm formulation, supplied quantity and renewal terms. Full price detailsCompounded tirzepatide offered; complete current selected-plan quote unknown; homepage advertises from $149/month while injection page starts at $239 with different supply options; earlier listing: From $239/mo (compounded) |
| Coverage | US only; restrictions by state, confirmed at intake | Program eligibility depends on clinician licensing and the selected medication; no complete current state roster was established |
| Brand-name access | Not confirmed | Current reviewed offers describe compounded injections; a separate branded GLP-1 program was not established. |
| Oral / sublingual | Injection only | Unconfirmed |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
Nex Gen Health Rx: Homepage starts at $99/month semaglutide and $149/month tirzepatide; injection pages instead start at $190/$239. Confirm selected formulation, supply and full payment.
Keep comparing
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.